Navigation Links
Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
Date:10/28/2008

- Data Presentation at 48th ICAAC / IDSA 46th Annual Meeting -

PRINCETON, N.J. and ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced results from a pilot study showing that the anthrax anti-toxin, Valortim(R) (MDX-1303), enhanced survival as compared to a control group in a therapeutic animal model known as the New Zealand White (NZW) rabbit model. Valortim is a fully human monoclonal antibody generated by Medarex's UltiMAb(R) technology that is being co-developed by the two companies for potential use as an anti- toxin therapeutic to prevent and treat inhalation anthrax.

The data were presented in an oral presentation entitled "Therapeutic Efficacy of MDX-1303, an Anti-toxin Monoclonal Antibody, for Inhalation Anthrax in the New Zealand White (NZW) Rabbit Model" at the 48th ICAAC/ IDSA 46th Annual Meeting by Israel Lowy, M.D., Ph.D., Senior Director of Clinical Science and Infectious Diseases at Medarex.

David P. Wright, President & Chief Executive Officer of PharmAthene, commented, "Mounting evidence from a number of animal studies suggests that Valortim may be efficacious as both a prophylactic and therapeutic for inhalation anthrax infection. Based on these results, we believe that Valortim is ideally positioned for procurement consideration in the Strategic National Stockpile,
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, ,, BOCARATON,Fla.,Nov.25/PRNewswir...oforBodyLogicMD.Thenation,slargestandfastestgrowin...nmedicallysupervised bioidenticalhormones has grow...ber2008-from21to36physicians -andisinprogresstoadd...o,bytheendofthisyear. ,, Inthepastyear ,BodyLog...
(Date:11/24/2009)... , This release is available in German . ,...ication cards: RFID tags (Radio Frequency Identifi...eryday life. They make it possible to label object...o frequency. The appropriate scanner can read and ...els can be affixed to goods under production condi...
(Date:11/24/2009)... ,, CALGARYandBLENHEIM,Ontario,Nov.24/PRNews...ayitisacquiringtheassetsofHylandSeeds,adivisionofT...andSeedswillfurtherexpandDowAgroSciences,currentse...f SmartStax(TM) in 2010 andDowAgroSciencesHerbic...ionalcloseisexpectedinthenearfuture. ,, "Thisac...
(Date:11/24/2009)... ,, SHANGHAI,Nov.24/PRNewswire-Asia/--NODPha...kOffice(PTO)hasallowedthepatentapplicationfor,itsn...Dtechnologyisahighlyefficientapproachtoincorporate...oenableoraldeliveryofdrugs,otherwiseadministeredas...canbeappliedtomanymacromoleculardrugssuchasinsulin...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...tated serum, tissue and blood samples are ... DALLAS-FORT WORTH, Texas, Jan. 9 Oncology Metri... to help accelerate,advancements in the treatment ...anagement company dedicated to innovation in human...laborate on oncology biospecimen,procurement and m...
...kforce Alliance, the,non- profit organization that...y, is closing a grant program that enabled over ni...pare for employment in the life sciences and,biote...ars., The Workforce Alliance,s expiring Biotechno...ent of Labor,s High Growth Job Training,Initiative...
...isk, a,healthcare company with an 84-year history ...day announced the appointment of Alan C. Moses, M....ide. Moses is currently the,chief medical officer ...., "Alan has the unique talent to integrate the s... critical asset that will deepen Novo Nordisk,s,le...
Other Biology Technology:Oncology Metrics and Cureline Announce Joint Marketing Agreement 2Oncology Metrics and Cureline Announce Joint Marketing Agreement 3Workforce Alliance Concludes Three-Year Biotech Training Program 2Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide 2
(Date:11/25/2009)...he course of a lifetime, the heart pumps some 250 ...rder to do this, the muscle fibers of the heart ha...ded by Dr. Wolfgang Rottbauer, vice chair of the D... Hospital (Chairman: Prof. Dr. H. A. Katus), has d...ability of the smallest muscular unit, the sarcome...
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...omic-level action of a remarkable class of ring-sh...ers with the Lawrence Berkeley National Laboratory...rystallography beamline at the Advanced Light Sour...in gene expression and replication, and are vital ...s infectious agents, such as the human papillomavi...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 1Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 2Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 3Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 4Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 5Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 6Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 7Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 8Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 9Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 10Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 11Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 12Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 13Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 14Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 15Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 16Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 17Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 18Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 19Lilly Reports Solid Second Quarter 2009 Results Raises EPS Guidance 52357 20CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 1CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 2CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 3CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 4CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 5CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 6Looking Older Than You Are May Have Little to Do With Wrinkles 13131 1Looking Older Than You Are May Have Little to Do With Wrinkles 13131 2Looking Older Than You Are May Have Little to Do With Wrinkles 13131 3
... is available in German . , A few days before ...n the Stem Cell Act, the Deutsche Forschungsgemein...orced its stance on amending current legislation. ...trongly impedes German stem cell research, explain..., while participating in a live chat session on th...
...H - Francis S. Collins, M.D., Ph.D., a physician-g...has been named recipient of the inaugural Inamori ... for Ethics and Excellence at Case Western Reserve...tstanding international ethical leaders. It is pre...ted exemplary ethical leadership and whose actions...
...., April 9. . . Two new studies presented at the ...n all-natural dietary supplement made from citrus ...lood glucose numbers after a meal and their LDL-ch...K Synergize Incs Scientific Director, said, ,Our ...shown that Diabetinol improves blood glucose numbe...
Other Biology News:Qualifying date rule hinders German stem cell research 2Qualifying date rule hinders German stem cell research 3Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve 2Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve 3People with diabetes may have all natural citrus supplement 2People with diabetes may have all natural citrus supplement 3
Goat Anti-Human Jagged 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Goat Anti-Mouse / Rat WNK1 Polyclonal Antibody, Unconjugated from R&D Systems
Griess Reagent R1 from Cayman Chemical
Recalibration of HL-2000-CAL products from Ocean Optics
Biology Products: